Mark J. Murray
Director/Miembro de la Junta en Genevant Sciences Corp. .
Cargos activos de Mark J. Murray
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Director/Miembro de la Junta | - | - |
Historial de carrera de Mark J. Murray
Antiguos cargos conocidos de Mark J. Murray.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Director/Miembro de la Junta | 14/10/2011 | 24/06/2019 |
| Director Ejecutivo | 30/05/2008 | 24/06/2019 | |
| Presidente | 30/05/2008 | 24/06/2019 | |
Protiva Biotherapeutics, Inc.
 Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Director Ejecutivo | 01/09/2000 | 02/12/2008 |
| Fundador | 02/12/2008 | 02/12/2008 | |
| Presidente | - | 02/12/2008 |
Formación de Mark J. Murray.
| Oregon Health & Science University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Canadá | 3 |
Operativa
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| President | 2 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| Empresas privadas | 2 |
|---|---|
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Health Technology |
- Bolsa de valores
- Insiders
- Mark J. Murray
- Experiencia
